Covance Clinical Research Unit is categorized under Testing Laboratories in Madison, WI .
Covance Clinical Research Unit was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Testing Laboratories business, which does work in the B2B market, and is classified as a Testing Laboratories, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Mary Westrick, Finance Executive at the company’s single location by writing to 3402 Kinsman Boulevard, Madison, Wisconsin WI 53704 or by phoning (608) 442-8200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Covance Clinical Research Unit |
| Contact Person: | Mary Westrick, Finance Executive |
| Address: | 3402 Kinsman Boulevard, Madison, Wisconsin 53704 |
| Phone Number: | (608) 442-8200 |
| Website Address: | covance.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Testing Laboratories |
| SIC Code: | 8734 |
| NAICS Code: | 5417110 |
| Share This Business: |
Covance Clinical Research Unit was started in 0 to provide professional Testing Laboratories under the SIC code 8734 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Mary Westrick, Finance Executive for inquiries that concern Covance Clinical Research Unit by calling the company number (608) 442-8200, as your correspondence is most welcome. Additionally, the physical location of the single location of Covance Clinical Research Unit can be found at the coordinates 43.12595,-89.33188 as well as the street address 3402 Kinsman Boulevard in Madison, Wisconsin 53704.
For its online presence, you may visit Covance Clinical Research Unit’s website at covance.com and engage with its social media outlets through on Twitter and on Facebook.